Entyvio®

$3,999.00

Entyvio is an integrin receptor antagonist used to treat adult patients with ulcerative colitis and Crohn’s disease. This product is manufactured by Takeda Pharmaceuticals, a Japanese pharmaceutical company.

Quantity Price
1 - 5 $3,999.00
6 - 10 $3,989.00
11 - 20 $32,984.00
21+ $3,979.00
Compare
Compare

Description

What is this product?

Entyvio is an integrin receptor antagonist used to treat adult patients with ulcerative colitis and Crohn’s disease. This product is manufactured by Takeda Pharmaceuticals, a Japanese pharmaceutical company. Entyvio is used for injection and supplied in a single-dose vial for injection.

What is it made of?

Entyvio 300mg contains vedolizumab, a humanized immunoglobulin G1 monoclonal antibody sourced from Chinese hamster ovary cells.

Reviews

There are no reviews yet.

Be the first to review “Entyvio®”

Your email address will not be published. Required fields are marked *